A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Cancer Genetics Education Program Bookmark and Share

Cancer Genetics Education Program

The Division of Clinical Cancer Genetics at City of Hope offers educational coursesand self-teaching tools forprofessionals in the fields of cancer and cancer genetics.ThisCancer Genetics Education Program (CGEP) is supported inpart by funding fromthe NCI (IRC4CA153828-01 andIR25CA112486).
 
Dramatic advances in our understanding of the genetic basis for cancer have led to the development of new technologies and tools for genetic cancer risk assessment. The Cancer Genetics Education Program at City of Hope offers a series of comprehensive learning tools designed to enhance the education of primary care physicians and clinical oncology professionals on the topics of cancer genetics and cancer risk assessment, and their application to patient care. Through a series of educational courses, workshops, seminars, newsletters and a direct, interactive electronic communications network, professionals can be tutored in the latest information on cancer molecular genetics, the fundamentals of obtaining an adequate family history, understanding genetic cancer risk assessment, ethical and legal complexities of genetic testing, and other current/timely topics.
 
Cancer Genetics Career Development Program
City of Hope offers an innovative  Cancer Genetics Career Development Program (CGCDP) whichprovides interdisciplinary training focused on cancer genetics and cancer prevention control research. The Traineeship is open to three applicants per year.
 
Intensive Course in Cancer Risk Assessment
City of Hope's Division of Clinical Cancer Genetics offers an annual CME/CEU-accredited multi-modal intensive course to address the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians.
 
Clinical Cancer Genetics Community of Practice
City of Hope CCG Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.

Working Group

Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team. CSPPN and affiliated clinicians across the U.S. present cases from their community practices via web conferencing for discussion and recommendations on risk assessment, surveillance, risk management and identification of research eligibility for cases covering the full spectrum of hereditary cancer.

2015 Clinical Cancer Genomics Update Conference

 
"From Evidence to Action: Next-Generation Approaches to Cancer Risk Assessment and Research"
City of Hope Division of Clinical Cancer Genetics (CCG), in collaboration with the University of Chicago, is excited to announce our 4th annual CME/CEU-accredited clinical cancer genetics and genomics update conference. The two-day conference will be held on Friday and Saturday, February 27 and 28, 2015, at City of Hope, Cooper Auditorium, in Duarte, CA.
 
 
 
 
 

Register early and save!
 
        Conference Fee Structure*         
CCGCoP**
members:
Non-CCGCoP
members:
Physicians $200 $275
Genetic Counselors $100 $175
Nurses & other Health Professionals (NP, PA, SW) $100 $175
Industry $200 $275
Resident/Fellow $75 $125

*After 12/28/14, all fees will increase by $50.
**Affiliation with City of Hope Division of Clinical Cancer Genetics CCGCoP & CCGCRN
 
  • Prices include breakfast and lunch on Friday and Saturday, and a fun-filled networking dinner on Friday evening!
 
  • A block of rooms has been secured at a rate of $132 for single occupancy and $66 for shared at the Courtyard by Marriott, Monrovia, February 26 to 28, 2015. Don’t miss out on this great rate! (Conference attendees who want to extend their stay at the hotel may contact Karen Gadsby, at  626-531-8008.)
 
 
 
 
To share accommodations with another conference attendee, contact Gloria Nunez at gnunez@coh.org no later than January 31, 2015.
 
 

Clinical Cancer Genetics Events Calendar

Cancer Genetics Education Program

Cancer Genetics Education Program

The Division of Clinical Cancer Genetics at City of Hope offers educational coursesand self-teaching tools forprofessionals in the fields of cancer and cancer genetics.ThisCancer Genetics Education Program (CGEP) is supported inpart by funding fromthe NCI (IRC4CA153828-01 andIR25CA112486).
 
Dramatic advances in our understanding of the genetic basis for cancer have led to the development of new technologies and tools for genetic cancer risk assessment. The Cancer Genetics Education Program at City of Hope offers a series of comprehensive learning tools designed to enhance the education of primary care physicians and clinical oncology professionals on the topics of cancer genetics and cancer risk assessment, and their application to patient care. Through a series of educational courses, workshops, seminars, newsletters and a direct, interactive electronic communications network, professionals can be tutored in the latest information on cancer molecular genetics, the fundamentals of obtaining an adequate family history, understanding genetic cancer risk assessment, ethical and legal complexities of genetic testing, and other current/timely topics.
 
Cancer Genetics Career Development Program
City of Hope offers an innovative  Cancer Genetics Career Development Program (CGCDP) whichprovides interdisciplinary training focused on cancer genetics and cancer prevention control research. The Traineeship is open to three applicants per year.
 
Intensive Course in Cancer Risk Assessment
City of Hope's Division of Clinical Cancer Genetics offers an annual CME/CEU-accredited multi-modal intensive course to address the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians.
 
Clinical Cancer Genetics Community of Practice
City of Hope CCG Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.

Working Group

Working Group

Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team. CSPPN and affiliated clinicians across the U.S. present cases from their community practices via web conferencing for discussion and recommendations on risk assessment, surveillance, risk management and identification of research eligibility for cases covering the full spectrum of hereditary cancer.

Cancer Genetics Community Link

Cancer Genetics Community Link Discussion Board

The Cancer Genetics Community Discussion Board is a Web-based discussion board for collaborative, interdisciplinary practice-based support and continuing professional learning. CCG Community of Practice members are encouraged to post and respond to case-based questions and share resources with a growing, multidisciplinary network of professionals engaged in the practice of clinical cancer genetics. Messages are posted and archived under topic-specific forums, allowing members to search for information by topic of interest.
 
Case Consultation Questions

Breast/Ovarian Cancers (Uninformative BRCA Test Results)

Breast/Ovarian Cancers (Testing)

Breast/Ovarian Cancers (Probability/Empiric Risks)

Breast/Ovarian Cancers (Risk Management)

Breast/Ovarian Cancers (Hormone Replacement Therapy)

Male Breast Cancers

Gastrointestinal Cancers (Lynch Related)

Gastrointestinal Cancers (Polyposis Syndromes)

Gastrointestinal Cancers (Non-Colorectal)

Gastrointestinal Cancers (Risk Management)

Genitourinary Cancer

Genodermatoses

Endocrine Neoplasias

Pediatric Cancers

ELSI-Ethical, Legal, Social Issues

 

Clinical Resources

Progeny/Pedigree Drawing Issues

 

Clinical Cancer Genetics Working Group

CCG Working Group Case Conferences

 

Comments/Suggestions

Suggestion/Comment Box

 

2015 Update Conference

2015 Clinical Cancer Genomics Update Conference

 
"From Evidence to Action: Next-Generation Approaches to Cancer Risk Assessment and Research"
City of Hope Division of Clinical Cancer Genetics (CCG), in collaboration with the University of Chicago, is excited to announce our 4th annual CME/CEU-accredited clinical cancer genetics and genomics update conference. The two-day conference will be held on Friday and Saturday, February 27 and 28, 2015, at City of Hope, Cooper Auditorium, in Duarte, CA.
 
 
 
 
 

Register early and save!
 
        Conference Fee Structure*         
CCGCoP**
members:
Non-CCGCoP
members:
Physicians $200 $275
Genetic Counselors $100 $175
Nurses & other Health Professionals (NP, PA, SW) $100 $175
Industry $200 $275
Resident/Fellow $75 $125

*After 12/28/14, all fees will increase by $50.
**Affiliation with City of Hope Division of Clinical Cancer Genetics CCGCoP & CCGCRN
 
  • Prices include breakfast and lunch on Friday and Saturday, and a fun-filled networking dinner on Friday evening!
 
  • A block of rooms has been secured at a rate of $132 for single occupancy and $66 for shared at the Courtyard by Marriott, Monrovia, February 26 to 28, 2015. Don’t miss out on this great rate! (Conference attendees who want to extend their stay at the hotel may contact Karen Gadsby, at  626-531-8008.)
 
 
 
 
To share accommodations with another conference attendee, contact Gloria Nunez at gnunez@coh.org no later than January 31, 2015.
 
 

Clinical Cancer Genetics Events Calendar

Clinical Cancer Genetics Events Calendar

Clinical Cancer Genetics
The City of Hope Division of Clinical Cancer Genetics is committed to being a national leader in the advancement of cancer genetics, screening and prevention, through innovative patient care, research and education.

Contact Us
  • 800-826-HOPE (4673)
  • For more information about the Cancer Screening & Prevention Program, call 626-256-8662, ext. 2.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
City of Hope Breakthroughs
Get the latest in City of Hope's research, treatment and news you can use on our blog, Breakthroughs.
 
 


NEWS & UPDATES
  • Equipping the immune system to fight cancer – a disease that thrives on mutations and circumventing the body’s natural defenses – is within reach. In fact, City of Hope researchers are testing one approach in clinical trials now. Scientists take a number of steps to turn cancer patients’ T cells – white b...
  • As treatments for lung cancer become more targeted and effective, the need for better technology to detect lung cancer mutations becomes increasingly important. A new clinical study at City of Hope is examining the feasibility of using blood and urine tests to detect lung cancer mutations, potentially allowing ...
  • When it comes to breast cancer risk, insulin levels may matter more than weight, new research has found. The study from Imperial College London School of Public Health, published in the journal Cancer Research, indicates that metabolic health – not a person’s weight or body mass index – increases breast cancer ...
  • No one ever plans to have cancer – and there’s never a good time. For Homa Sadat, her cancer came at a particularly bad time: just one year after losing her father to the pancreatic cancer he had battled for two years. She was working a grueling schedule managing three commercial office buildings. She’d just [&...
  • Patients at City of Hope – most of whom are fighting cancer – rely on more than 37,000 units of blood and platelets each year for their treatment and survival. Every one of those units comes from family, friends or someone who traded an hour or so of their time and a pint of their […]
  • Surgery is vital in the treatment of cancer – it’s used to help diagnose, treat and even prevent the disease – so a new colorectal cancer study linking a decrease in surgeries for advanced cancer to increased survival rates may raise more questions than it answers for some patients. The surgery-and-surviv...
  • Age is the single greatest risk factor overall for cancer; our chances of developing the disease rise steeply after age 50. For geriatric oncology nurse Peggy Burhenn, the meaning is clear: Cancer is primarily a geriatric condition. That’s why she is forging inroads in the care of older adults with cancer. Burh...
  • One of American’s great sportscasters, Stuart Scott, passed away from recurrent cancer of the appendix at the young age of 49. His cancer was diagnosed when he was only 40 years old. It was found during an operation for appendicitis. His courageous fight against this disease began in 2007, resumed again with an...
  • When Homa Sadat found a lump in her breast at age 27, her gynecologist told her what many doctors say to young women: You’re too young to have breast cancer. With the lump dismissed as a harmless cyst, she didn’t think about it again until she was at a restaurant six months later and felt […]
  • What most people call a “bone marrow transplant” is not actually a transplant of bone marrow; it is instead the transplantation of what’s known as hematopoietic stem cells. Such cells are often taken from bone marrow, but not always. Hematopoietic stem cells are simply immature cells that can ...
  • Doctors have long known that women with a precancerous condition called atypical hyperplasia have an elevated risk of breast cancer. Now a new study has found that the risk is more serious than previously thought. Hyperplasia itself is an overgrowth of cells; atypical hyperplasia is an overgrowth in a distorted...
  • Don’t kid yourself. Just because it’s mid-January doesn’t mean it’s too late to make resolutions for a happier, and healthier, 2015. Just consider them resolutions that are more mature than those giddy, sometimes self-deluded, Jan. 1 resolutions. To that end, we share some advice from Cary A. Presant, M.D., an ...
  • Sales and marketing executive Jim Murphy first came to City of Hope in 2002 to donate blood for a friend who was being treated for esophageal cancer. The disease is serious. Although esophageal cancer accounts for only about 1 percent of cancer diagnoses in the U.S., only about 20 percent of patients survive at...
  • Aaron Bomar and his family were celebrating his daughter’s 33rd birthday in September 2014 when he received alarming news: According to an X-ray taken earlier that day at an urgent care facility, he had a node on his aorta and was in danger of an aneurysm. Bomar held hands with his wife and daughter and s...
  • Explaining a prostate cancer diagnosis to a young child can be difficult — especially when the cancer is incurable. But conveying the need for prostate cancer research, as it turns out, is easily done. And that leads to action. Earlier this year, Gerald Rustad, 71, who is living with a very aggressive form of m...